Komatsu Ryuichi, Low-Beer Daniel, Schwartländer Bernhard
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Bull World Health Organ. 2007 Oct;85(10):805-11. doi: 10.2471/blt.06.038315.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is one of the largest funders to fight these diseases. This paper discusses the programmatic contribution of Global Fund-supported programmes towards achieving international targets and Millennium Development Goals, using data from Global Fund grants.
Results until June 2006 of 333 grants supported by the Global Fund in 127 countries were aggregated and compared against international targets for HIV/AIDS, tuberculosis and malaria. Progress reports to the Global Fund secretariat were used as a basis to calculate results. Service delivery indicators for antiretrovirals (ARV) for HIV/AIDS, case detection under the DOTS strategy for tuberculosis (DOTS) and insecticide-treated nets (ITNs) for malaria prevention were selected to estimate programmatic contributions to international targets for the three diseases. Targets of Global Fund-supported programmes were projected based on proposals for Rounds 1 to 4 and compared to international targets for 2009.
Results for Global Fund-supported programmes total 544,000 people on ARV, 1.4 million on DOTS and 11.3 million for ITNs by June 2006. Global Fund-supported programmes contributed 18% of international ARV targets, 29% of DOTS targets and 9% of ITNs in sub-Saharan Africa by mid-2006. Existing Global Fund-supported programmes have agreed targets that are projected to account for 19% of the international target for ARV delivery expected for 2009, 28% of the international target for DOTS and 84% of ITN targets in sub-Saharan Africa.
Global Fund-supported programmes have already contributed substantially to international targets by mid-2006, but there is a still significant gap. Considerably greater financial support is needed, particularly for HIV, in order to achieve international targets for 2009.
全球抗击艾滋病、结核病和疟疾基金是抗击这些疾病的最大资助者之一。本文利用全球基金赠款数据,探讨全球基金支持的项目在实现国际目标和千年发展目标方面的项目贡献。
汇总全球基金在127个国家支持的333个项目截至2006年6月的结果,并与艾滋病毒/艾滋病、结核病和疟疾的国际目标进行比较。向全球基金秘书处提交的进展报告用作计算结果的依据。选择了艾滋病毒/艾滋病抗逆转录病毒药物(ARV)的服务提供指标、结核病直接观察短程治疗策略(DOTS)下的病例发现以及预防疟疾的经杀虫剂处理蚊帐(ITN),以估算这些项目对三种疾病国际目标的项目贡献。根据第1至4轮的提案预测了全球基金支持项目的目标,并与2009年的国际目标进行比较。
截至2006年6月,全球基金支持的项目成果为:54.4万人接受抗逆转录病毒治疗,140万人接受结核病直接观察短程治疗,1130万人使用经杀虫剂处理蚊帐。到2006年年中,全球基金支持的项目在撒哈拉以南非洲地区实现了抗逆转录病毒治疗国际目标的18%、结核病直接观察短程治疗目标的29%和经杀虫剂处理蚊帐目标的9%。现有全球基金支持的项目商定的目标预计将占2009年抗逆转录病毒治疗国际目标的19%、结核病直接观察短程治疗国际目标的28%以及撒哈拉以南非洲地区经杀虫剂处理蚊帐目标的84%。
到2006年年中,全球基金支持的项目已对国际目标做出了重大贡献,但仍存在巨大差距。为实现2009年的国际目标,需要大幅增加财政支持,特别是对艾滋病毒防治的支持。